Perspectives of arterial hypertension control improvement by rational diuretic therapy: Russian research and clinical program ARGUS-2 results

Aim. As a part of ARGUS-2 program, to demonstrate the reserves for arterial hypertension (AH) control improvement, by rational monotherapy or combined therapy with diuretics in patients with uncontrolled AH in anamnesis: individuals with isolated systolic AH (ISAH), diabetes mellitus (DM), chronic nephropathy (CN), and metabolic syndrome (MS). Material and methods. This open, non-comparative study, without wash-out period, included 1438 patients (mean age 57,3 +/- 10,7 years, blood pressure, BP 158,8 +/- 14,2/93,4 +/- 10,0 mm Hg), not achieving target BP levels (< 140/<90 mm Hg or < 130/<80 mm Hg for DM or CN), and receiving non-diuretic therapy. Slow-release indapamide (Arifon(R) retard), in the dose of 1,5 mg, was administered once per day. Follow-up period lasted for 3 months. To achieve target BP levels, the physician could modify antihypertensive treatment regimen. Results. In total, 1399 patients (97,3%) completed the study. Arifon(R) retard was administered as monotherapy in 13,7% of the participants; as an alternative to previous ineffective monotherapy - in 6,8%; in addition to inadequately effective monotherapy - in 31,9%; and in addition to inadequately effective non-diuretic therapy - in 47,6%. Three months later, target BP level rate was 84,5%, mean BP level reduced to 131,8 +/- 9,7/80,5 +/- 6,9 mm Hg. Target BP was achieved in 91,9% (n=477) of ISAH patients, in 74,8% (n=214) of DM participants, in 75,6% (n=82) of CN individuals, and in 85, 1% (n=745) of MS patients. Conclusion. The study results confirmed the importance of low-dose thiazide diuretic therapy, as a part of combined treatment, in achieving target BP levels among patients with high or very high cardiovascular risk.

Vserossiiskoe Obshchestvo Kardiologov
Номер выпуска
Ключевые слова
uncontrolled arterial hypertension; isolated systolic hypertension; metabolic syndrome; chronic nephropathy; diuretics; Arifon (R) retard
Дата создания
Дата изменения
Постоянная ссылка

Другие записи

Kobalava Z.D., Villevalde S.V., Shavarova E.K.
Cardiovascular Therapy and Prevention (Russian Federation). Vserossiiskoe Obshchestvo Kardiologov. Том 6. 2007. С. 105-112